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Since the 1995 publication of its Core Cardiovascular
Training Statement (COCATS), the American College of
Cardiology (ACC) has played a central role in deﬁning
the knowledge, experiences, skills, and behaviors ex-
pected of all clinical cardiologists upon completion of
training. Subsequent updates have incorporated major
advances and revisions—both in content and structure—
including, most recently, a further move toward com-
petency (outcomes)-based training, and the use of the
6-domain competency structure promulgated by the
Accreditation Council for Graduate Medical Education
(ACGME) and the American Board of Medical Specialties,
and endorsed by the American Board of Internal Medi-
cine (ABIM). A similar structure has been used by ACC to
describe the aligned general cardiovascular lifelong
learning competencies that all practicing cardiologists
are expected to maintain. Many hospital systems also
now use the 6-domain structure as part of medical staff
privileging and peer-review professional competence
assessments.
Whereas COCATS has focused on general clinical car-
diology, ACC Advanced Training Statements deﬁne
selected competencies that go beyond those expected of
all cardiologists and require training beyond a standard
3-year cardiovascular disease fellowship. This includes
sub-subspecialties for which there is an ABIM added-
qualiﬁcation designation, such as clinical cardiac elec-
trophysiology (CCEP). The Advanced Training State-
ments also describe key experiences and outcomes
necessary to maintain or expand competencies during
practice.
The ACC Competency Management Committee over-
sees the development and periodic revision of the car-
diovascular training and competency statements. A key
feature of competency-based training and performance
is an outcome-based evaluation system. Although spe-
ciﬁc areas of training may require a minimum number ofprocedures or duration of training time to ensure
adequate exposure to the range of clinical disorders and
to effectively evaluate the trainee, it is the objective
assessment of proﬁciency and outcomes that demon-
strates the trainee’s achievement of competency. Such
evaluation tools may include in-training examinations,
direct observation, procedure logbooks, simulation,
conference presentations, and multisource (360) evalua-
tions, among others. For practicing physicians, these tools
may also include professional society registry or hospital
quality data, peer-review processes, and patient satisfac-
tion surveys. A second feature of a competency-based
training program is the recognition that learners develop
some competency components at different rates. For
multiyear training programs, assessment of selected
representative curricular milestones during training can
identify learners or areas that require additional focused
attention.
The recommendations in the ACC cardiovascular
training statements are based on available evidence,
and where evidence is lacking, reﬂect expert opinion.
The writing committees are broad-based, and typically
include content experts, general cardiology and sub-
subspecialty training directors, practicing cardiologists,
and early-career representatives. All documents go
through a rigorous peer-review process. Recommenda-
tions are intended to guide the assessment of compe-
tence of cardiovascular care providers beginning
independent practice as well as those undergoing pe-
riodic review to help ensure that competence is
maintained.
This Advanced Training Statement addresses the added
competencies required of sub-subspecialists in CCEP for
diagnosis and management of patients with cardiac arrhyth-
mias and conduction disturbances at a high level of skill. It is
intended to complement the basic training in cardiac electro-
physiology (EP) required of all trainees during the standard 3-
year cardiovascular fellowship. The training requirements and
designated clinical competencies in this report focus on the
core competencies reasonably expected of all clinical cardiac
electrophysiologists. It also identiﬁes some aspects of CCEP
that go beyond the core expectations andmay be achieved by
some clinical cardiac electrophysiologists, based on career
focus, either during formal CCEP fellowship training or
subsequently.
The work of the writing committee was supported
exclusively by the ACC without commercial support.
Writing committee members volunteered their time to
this effort. Conference calls of the writing committee
were conﬁdential and attended only by committee
members. To avoid actual, potential, or perceived con-
ﬂict of interest arising as a result of relationships with
industry or other entities (RWI) of writing committee
members or peer reviewers of the document, each
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2770individual is required to disclose all current healthcare-
related relationships, including those existing 12
months before initiation of the writing effort. The ACC
Competency Management Committee reviewed these
disclosures to identify products (marketed or under
development) pertinent to the document topic. On the
basis of this information, the writing committee was
constituted to ensure that the Chair and a majority of
members have no relevant RWI. Authors with relevant
RWI were not permitted to draft initial text or vote on
recommendations or curricular requirements to which
their RWI might apply. RWI was reviewed at the start of
all meetings and conference calls and updated as
changes occurred. The RWI of authors and peer re-
viewers relevant to this document are disclosed in
Appendixes 1 and 2, respectively. To ensure trans-
parency, comprehensive healthcare-related disclosure
information, including RWI not pertinent to this docu-
ment, is posted online. Disclosure information for the
ACC Competency Management Committee is also avail-
able online, as is the ACC disclosure policy for document
development.
Eric S. Williams, MD, MACC
Chair, ACC Competency Management Committee
Jonathan L. Halperin, MD, FACC
Co-Chair, ACC Competency Management Committee1. INTRODUCTION
1.1. Document Development Process
1.1.1. Writing Committee Organization
The writing committee consisted of a broad range of
members representing ACC, the American Heart Asso-
ciation (AHA), and the Heart Rhythm Society (HRS),
identiﬁed because they perform $1 of the following
roles: cardiovascular training program directors; EP
training program directors; early-career experts; general
cardiologists; EP specialists representing both the aca-
demic and community-based practice settings as well as
small, medium, and large institutions; specialists in all
aspects of CCEP, including catheter ablation, device
management, antiarrhythmic drug therapy, lead extrac-
tion, and left atrial appendage occlusion/ligation; phy-
sicians experienced in training and working with the
ACGME/Residency Review Committee as well as the
ABIM examination writing committee; physicians expe-
rienced in deﬁning and applying training standards
according to the 6 general competency domains
promulgated by the ACGME and the American Board of
Medical Specialties and endorsed by the ABIM; and
nurses. This writing committee met the College’s
disclosure requirements for relationships with industry
as described in the Preamble.1.1.2. Document Development and Approval
The writing committee convened by conference call and
e-mail to ﬁnalize the document outline, develop the
initial draft, revise the draft based on committee feed-
back, and ultimately approve the document for external
peer review. In addition, the committee conducted a
survey of EP training program directors to obtain addi-
tional insight into procedural numbers to consider in
writing committee deliberations.
The document was reviewed by 9 ofﬁcial representa-
tives from the ACC, AHA, and HRS, as well as by 26
additional content reviewers, including CCEP training
program directors, resulting in 417 peer review com-
ments. The list of peer reviewers, afﬁliations for the re-
view process, and corresponding RWI is included in
Appendix 2. Comments were reviewed and addressed by
the writing committee. A member of the ACC Competency
Management Committee served as lead reviewer to
ensure a fair and balanced peer review resolution process.
Both the writing committee and the ACC Competency
Management Committee approved the ﬁnal document to
be sent for organizational approval. The governing bodies
of the ACC, AHA, and HRS approved the document for
publication. This document is considered current until
the ACC Competency Management Committee revises or
withdraws it from publication.1.2. Background and Scope
The original 1995 ACC recommendations for training
in adult cardiology evolved from a Core Cardiology
Training Symposium (1). After several iterations, COCATS
4 (2) focuses on trainee outcomes that require delineation
of speciﬁc components of competency within the sub-
specialty, deﬁnition of the tools necessary to assess
training, and establishment of milestones documenting
the trainee’s progression toward independent compe-
tency. Ultimately, the goal is for the trainee to develop the
professional skill set to be able to evaluate, diagnose, and
treat patients with acute and chronic cardiovascular
disturbances.
The COCATS 4 document includes individual task
force reports that address subspecialty areas in cardiol-
ogy, each of which is an important component in
training a fellow in cardiovascular disease. Task Force 11
of that document addresses training in arrhythmia
diagnosis and management, cardiac pacing, and EP (3)
and updated previous standards for general cardiovas-
cular training for fellows enrolled in cardiovascular
fellowship programs. It addresses faculty, facilities,
equipment, and ancillary support. It also addresses
training components, including didactic, clinical, and
hands-on experience, and the number of procedures and
duration of training. Importantly, the COCATS 4 Task
J A C C V O L . 6 6 , N O . 2 4 , 2 0 1 5 Zipes et al.
D E C E M B E R 2 2 , 2 0 1 5 : 2 7 6 7 – 8 0 2 2015 ACC/AHA/HRS CCEP Advanced Training Statement
2771Force 11 report did not provide speciﬁc guidelines for
advanced CCEP training.
This document focuses on training requirements for
advanced training in adult CCEP. For training standards
related to pediatric EP, readers should refer to the
SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric
Cardiology Fellowship Programs Task Force 4: Pediatric
Cardiology Fellowship Training in Electrophysiology (4)
and to Recommendations for Advanced Fellowship
Training in Clinical Pediatric and Congenital Elec-
trophysiology: a Report From the Training and Cre-
dentialing Committee of the Pediatric and Congenital
Electrophysiology Society (5).
1.2.1. Evolution of CCEP
Training in CCEP has become more complex as the clinical
specialty has matured. The use of cardioactive drugs,
implantation and use of cardiac implantable electronic
devices (CIEDs) and left atrial appendage occlusion de-
vices, and performance of invasive catheter ablation
procedures for arrhythmia management have reached a
level of sophistication that necessitates a re-evaluation of
the training curriculum.
The ABIM requires 3 years of cardiology fellowship
training before fellows may sit for the certiﬁcation ex-
amination in cardiovascular medicine. Previously, it had
required an additional year of training in CCEP for eligi-
bility to take the certiﬁcation examination in EP. It is now
clear that CCEP demands a skill level to diagnose and treat
patients with cardiac arrhythmias and conduction disor-
ders that can no longer be attained in a single year of
training. Two years of advanced training are now required
to achieve the experience necessary to become a compe-
tent, independent expert in CCEP.
1.2.2. Levels of Training
COCATS 4 Task Force 11 was charged with updating
previously published standards for training fellows in
cardiovascular medicine and establishing consistent
training criteria across all aspects of cardiology including
advanced training in CCEP (3). For the cardiovascular
fellowship, the following 3 levels of training have been
delineated for training in arrhythmia diagnosis and
management, cardiac pacing, and EP:
 Level I training, the basic training required of trainees
to become competent consultant cardiologists, is
required of all fellows in cardiology, and can be
accomplished as part of a standard 3-year training
program in general cardiology.
 Level II training, refers to additional training in $1 area
that enables some cardiologists to perform or interpret
speciﬁc procedures or render more specialized care for
patients with certain conditions. Level II training inselected areas may be achieved by some trainees dur-
ing the standard 3-year cardiovascular fellowship,
depending on their career goals and use of elective
rotations. Level II EP training during the general
fellowship can provide the knowledge and skills
needed for the fellow to provide specialized arrhythmia
and CIED management, including implantation, inter-
rogation and programming of pacemakers and
implantable loop recorders (ILRs), and interrogation
and programming of other CIEDs.
 Level III training, the primary focus of this document,
requires additional training and experience beyond
the cardiovascular fellowship for the acquisition of
specialized knowledge and experience in performing,
interpreting, and training others to perform speciﬁc
procedures or render advanced, specialized care for
speciﬁc procedures at a high level of skill. Level III
training is required of individuals seeking subspecialty
board certiﬁcation in CCEP. Trainees in CCEP are
expected to have completed Level I training in all areas
of general cardiovascular medicine before beginning
their CCEP fellowship.1.2.3. Methods for Determining Procedural Numbers
As noted in the COCATS 4 Task Force 11 report (3), the
recommended number of procedures performed and
interpreted by trainees under faculty supervision has
been developed on the basis of published studies and
guidelines, competency statements, and the experience
and opinions of the members of the writing group. In
addition, the writing committee surveyed CCEP training
program directors to gain additional insight into proce-
dural volumes. Of 100 directors of ABIM–recognized
training programs, 33 responded. The procedural volumes
suggested in this document were determined to be the
minimum numbers sufﬁcient to provide trainees with
exposure to a variety and spectrum of complexity of
clinical case material and to give supervising faculty
sufﬁcient opportunity to evaluate the competency
developed by each trainee. The numbers of procedures
that should be performed and/or interpreted successfully
to achieve competence (see Section 4.2) are intended as
general guidance, based on the educational needs and
progress of typical CCEP trainees in typical programs.
Those considering these volume ﬁgures should bear in
mind the fundamental nature of educational milestones—
that proﬁciency and outcomes, rather than length of
exposure or the exact number of procedures performed,
are the dominant requirements. Flexibility is inherent to
this concept, and the ACGME mandates that all programs
establish milestones for the acquisition of various com-
petencies by trainees during the course of fellowship
training.
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2.1. Faculty
Engaged faculty who are committed to teaching EP are the
most important resource for a successful CCEP training
program. Faculty must include specialists who are
knowledgeable about basic and clinical aspects of EP,
including anatomy, physiology, and pathophysiology of
arrhythmias; both noninvasive and invasive diagnostic
strategies and tests; and therapeutic options, including
device-based therapies, medical management, and
catheter ablation. The most recent ACGME Program
Requirements for Graduate Medical Education in CCEP
require a single designated program director and at
least 1 additional key clinical faculty member (6). Each
of the key clinical faculty members should be currently
certiﬁed in CCEP by the ABIM. Furthermore, it is rec-
ommended that the number of ABIM-certiﬁed EP faculty
equal or exceed the number of trainees enrolled in the
training program. In addition to subject knowledge,
faculty should be active both clinically and academically
in the ﬁeld of EP; should have experience and/or un-
dergo professional training in teaching and mentoring;
and must have sufﬁcient time to fulﬁll the teaching,
mentoring, and administrative responsibilities required
for participation as active faculty in the CCEP training
program.
2.2. Facilities
Facilities must include dedicated areas for both outpa-
tient care and hospital-based treatment. An outpatient
area that allows for longitudinal management of patients
with arrhythmia problems is essential for complete
training. In the hospital environment, a dedicated
area that provides a safe and sterile environment for
performing invasive electrophysiological procedures is
necessary. The “Heart Rhythm Society Expert Consensus
Statement on Electrophysiology Laboratory Standards:
Process, Protocols, Equipment, Personnel, and Safety”
provides general recommendations for the EP laboratory
(7). In addition to physical space and facilities, the
teaching environment must include a systems-based
practice that allows for effective communication be-
tween the outpatient and inpatient environments and
among different specialists. Facilities must also have
systems or mechanisms in place that continuously eval-
uate quality and clinical outcomes.
2.3. Equipment
EP laboratories that provide a safe environment for
invasive EP studies require imaging capabilities such
as ﬂuoroscopy and equipment for recording electrical
and hemodynamic signals. In addition, specializedequipment, including alternative imaging methods (e.g.,
intracardiac echocardiography), advanced 3-dimensional
mapping systems, ablation energy sources, CIED pro-
grammers, and extraction tools, is often necessary for
safe andmaximally-effective care of patients within the EP
laboratory. Appropriate resuscitation equipment must
be immediately available. In addition to facilities recom-
mendations, the HRS Expert Consensus Statement on
Electrophysiology Laboratory Standards: Process, Pro-
tocols, Equipment, Personnel, and Safety provides
detailed recommendations on equipment necessary for
performing invasive EP studies and placing CIEDs (7).
Equipment and technology in the EP laboratory will
continue to evolve rapidly, and a mechanism must be
present that allows assessment and integration of impor-
tant new technologies. In addition to equipment physically
located within the EP suite, access to equipment and
technologies outside of the EP suite, such as trans-
esophageal echocardiography and advanced imaging (e.g.,
computed tomography [CT] scanning, cardiovascular
magnetic resonance [CMR]), is essential for successful
training in EP.
2.4. Ancillary Support
Adequate EP training requires interaction among many
different specialties within the healthcare environment.
Communication with, and access to, cardiologists who
have advanced training in interventional cardiology,
echocardiography and advanced imaging, and heart
failure are critical. In addition, interaction with and
availability of anesthesiologists and cardiothoracic sur-
geons are important for safe performance of some
advanced EP procedures. Physicians from other ﬁelds
of medical and surgical practice should be available
for consultation, and access to other healthcare pro-
fessionals, including genetic counselors, pharmacists,
dieticians, occupational therapists, physical therapists,
social workers, and biomedical engineers, is required.
3. TRAINING COMPONENTS
3.1. Didactic Program
Didactic instruction may take place in a variety of for-
mats, including lectures, conferences, journal club, grand
rounds, clinical case presentations, electrocardiogram
(ECG) and electrogram review conferences, and patient
safety or quality improvement conferences. Topics for
discussion include genetics; anatomy; neural innervation;
pathology; molecular, cellular, whole-animal and human
EP; radiation safety; imaging; speciﬁc arrhythmia mech-
anisms; and patient-centered care. Didactic sessions and
case reviews are important mechanisms for training in
the interpretation of complex surface and intracardiac
electrograms and in the evaluation and management of
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rhythmias. The latter includes the interpretation of
ambulatory monitoring and CIED data critical for patient
management. Hands-on use of simulators is an emerging
platform to assist in the training of electrophysiologists,
particularly in areas such as lead extraction, lead
placement, trans-septal puncture, catheter ablation pro-
cedures, and preparation for infrequent emergencies such
as cardiac perforation and tamponade (8,9). The same
requirements for frequency of didactic instruction in
general cardiology training are recommended for Level III
training in CCEP (3). Moreover, it is expected that the
CCEP trainees embark on a lifelong journey of education
and learning that does not end with the completion of
the fellowship, especially as new technologies and pro-
cedures are developed.
3.2. Clinical Experience
Level III trainees are required to have completed Level I
training. Level II training can be completed before or in
conjunction with Level III training. In either situation,
Level III training cannot start until 3 years of cardiovas-
cular training have been completed. Level III training re-
quires robust clinical experiences in the outpatient and
inpatient consultation settings and in the EP laboratory.
In each of these clinical arenas, trainees assist in patient
care in a supervised setting that provides for patient-
centered education in all aspects of arrhythmia manage-
ment. During a portion of clinical training, the Level III
trainee is expected to act as a ﬁrst-line consultant in
arrhythmia management with appropriate on-site
attending backup. In this capacity, the Level III trainee
is expected to gather accurate, essential information from
all sources, including medical interviews, physical ex-
amination, records, device interrogation, and diagnostic/
therapeutic procedures; make informed recommenda-
tions about preventive, diagnostic, and therapeutic op-
tions and interventions that on the basis of clinical
judgment, scientiﬁc evidence, and patient preferences;
develop, negotiate, and implement patient management
plans; and perform competently the diagnostic and ther-
apeutic procedures considered essential to the practice of
CCEP.
3.3. Hands-On Procedural Experience
Hands-on experience is essential for training in
arrhythmia and CIED management. Level III training in
CCEP requires a robust experience in the EP laboratory
performing diagnostic and therapeutic EP procedures and
device implantation and programming (permanent pace-
makers, implantable cardioverter-deﬁbrillators [ICDs],
and cardiac resynchronization therapy [CRT] devices).
The number of procedures that need to be completedduring the 24 months of CCEP training is summarized in
Section 4.2.
Level III trainees require experience in performing
diagnostic EP studies and standard ablation procedures
including ablation of atrioventricular (AV) nodal re-
entrant tachycardia, atrial ﬂutter, atrial tachycardia,
accessory pathways (APs), the AV node, and ventricular
arrhythmias (VAs). They also require experience in
endocardial mapping including exposure to left heart
mapping by the retrograde aortic and trans-septal ap-
proaches. Performance of procedures such as atrial
ﬁbrillation (AF) ablation, ablation of left-sided APs, and
placement of left atrial appendage occlusion devices/
ligation requires training in trans-septal catheterization.
Ablation of AF, atrial tachycardia, premature ventricular
complexes, and ventricular tachycardia (VT) requires
additional expertise in catheter manipulation, delivery of
ablative energy, and integration of knowledge related to
3-dimensional mapping systems and supporting modal-
ities, such as intracardiac echocardiograms, CMR, and
CT scans.
To gain skills in CIED implantation, the trainees
should have adequate supervised experience perform-
ing this procedure (see Section 4.2). CIED lead extrac-
tion is a specialized procedure that requires special
training but is not required to qualify for CCEP exam-
ination eligibility. Level III training in ICD implantation
requires an extensive knowledge of ICD indications and
contraindications, and of management of complications;
an ability to assess patients for their risk of elevated
deﬁbrillation thresholds (DFTs), determine DFTs when
appropriate, and manage high DFTs; an understanding
of drug- and pacemaker-ICD interactions; and a thor-
ough knowledge of ICD programming, management of
ICD malfunction, and postoperative complications.
Level III trainees must have an extensive knowledge
of left ventricular lead indications and contrain-
dications, management of biventricular pacemaker
malfunctions and interactions, and postoperative com-
plications (10).
Cardiac EP is a rapidly evolving ﬁeld, and the ongoing
introduction of new technology can be expected. These
new technologies include leadless pacing systems, left
atrial appendage exclusion devices, renal denervation
procedures, implantable hemodynamic and pressure
monitors, and novel methods for arrhythmia mapping.
Therefore, although speciﬁc requirements for trainees in
these new technologies cannot be stipulated, Level III
trainees will be expected to attain the same minimum
number of supervised procedures recommended for
practicing electrophysiologists in the future. In addition,
the increase in the number of left ventricular assist de-
vices and the growth of the adult with congenital heart
disease population introduce speciﬁc, unquantiﬁable
Zipes et al. J A C C V O L . 6 6 , N O . 2 4 , 2 0 1 5
2015 ACC/AHA/HRS CCEP Advanced Training Statement D E C E M B E R 2 2 , 2 0 1 5 : 2 7 6 7 – 8 0 2
2774patient-based complexities. Performance of procedures
in these special populations may be limited to certain
centers that expose trainees to a larger number of these
patients.
3.4. Diagnosis and Management of Emergencies and
Complications
The nature of procedures performed in the practice of
CCEP raises the real possibility of potential complications
that range from minor to major, including those that are
immediate and life threatening. It is critical that the Level
III trainee be proﬁcient at recognizing potential compli-
cations for each type of procedure being performed and
understand safeguards that must be in place to minimize
risk. In addition, the Level III trainee must become pro-
ﬁcient at managing acute intraprocedural complications
as well as postprocedural complications. Potential com-
plications include death, vascular disruption (e.g., at an
access site or during lead extractions), pulmonary emboli,
respiratory compromise, stroke, infection (either device-
related or not device-related), cardiac perforation with
effusion and/or tamponade, hemothorax, pneumothorax,
venous thromboses (both those related to CIED implan-
tation and those that are not device related), phrenic nerve
paralysis, atrial esophageal ﬁstula (following AF ablation),
and air embolism. The Level III trainee must be proﬁcient
at managing those complications that can be treated by the
electrophysiologist, as well as understanding when addi-
tional support is needed from cardiothoracic surgery,
interventional cardiology, or anesthesiology. The Level III
trainee is expected to follow institutional requirements
for reporting complications, present and discuss them
at patient safety or quality improvement conferences,
and learn from such experiences.
3.5. Diagnosis and Management of Rare Clinical Conditions
and Syndromes
A large number of hereditary conditions can be associated
with cardiac arrhythmias, and the Level III trainee must be
familiar with inherited ion channel disorders such as long
QT syndrome, Brugada syndrome, short QT syndrome,
and catecholaminergic polymorphic VT as well as with
inherited cardiomyopathies that have arrhythmic mani-
festations including hypertrophic cardiomyopathy,
arrhythmogenic right ventricular dysplasia/cardiomyopa-
thy, myotonic dystrophy, other muscular dystrophies, and
other types of cardiomyopathies. In addition, numerous
autoimmune and inﬂammatory disorders have potential
electrophysiological manifestations. The Level III trainee
shall develop clinically applicable knowledge of the basic
and clinical sciences that underlie these disorders and
apply this knowledge in patient care. The Level III trainee
is not expected to be expert in the complete management
of patients with these conditions and syndromes but mustbe able to use information technology or other available
methodologies, including consultation with genetic
counselors, clinical geneticists, and experts in these con-
ditions, to diagnose and manage affected patients.
3.6. Research and Scholarly Activity
All trainees are expected to carry out scholarly activities
and/or research during Level III training in CCEP. Level
III training in CCEP may include structured activities
designed to support careers in cardiovascular investiga-
tion (11). However, not all Level III CCEP trainees are ex-
pected to follow this route. During Level III training, the
trainee is expected to work with a mentor(s) to develop
areas of scholarly achievement. Scholarly activity may
include original clinical, basic science, or translational
research; quality improvement activities; presentation at
institutional, local, regional, or national meetings; and
publication of original articles, reviews, chapters, or case
reports. In addition, a scholarly approach to answering
clinical questions and enhancing patient care through
conducting literature reviews should be promoted
throughout the fellowship years. Trainees should be en-
couraged to develop and maintain habits of self-learning,
particularly through regular reading of cardiology and
CCEP journals and attending appropriate scholarly meet-
ings. Progress in research and scholarly training is
assessed by the program director and instructors through
evaluation tools such as direct observation, reviewing
presentations and manuscripts, and overseeing research
activities.
4. TRAINING REQUIREMENTS
4.1. Development and Evaluation of Core Competencies
Training and requirements in CCEP address the 6 general
competencies promulgated by the ACGME and American
Board of Medical Specialties and endorsed by the ABIM.
These competency domains are: medical knowledge, pa-
tient care and procedural skills, practice-based learning
and improvement, systems-based practice, interpersonal
and communication skills, and professionalism. The ACC
has used this structure to deﬁne and depict the compo-
nents of the clinical competencies for cardiology. The
curricular milestones for each competency and domain
also provide a developmental roadmap for fellows as they
progress through various levels of training and serve as an
underpinning for the ACGME reporting milestones. The
ACC has adopted this format for its competency and
training statements, career milestones, lifelong learning,
and educational programs.
Table 1 delineates each of the 6 competency domains,
as well as their associated curricular milestones for
training in CCEP. Included in the table are examples of
evaluation tools suitable for assessing competence in
TABLE 1 Competency Components and Curricular Milestones for Level III Training in Clinical Cardiac Electrophysiology
Competency Component Milestones (Months)
MEDICAL KNOWLEDGE 12 24 Add
Pathophysiological Basis of Cardiac Arrhythmias/Basic Electrophysiology
1. Know normal cardiac anatomy, including the anatomy of the conduction system. III
2. Know basic cardiac electrophysiology. III
3. Know the mechanisms of cardiac arrhythmias, including the relationship between cardiac arrhythmias and
structural heart disease (including congenital heart disease), sympathetic as well as parasympathetic tone,
myocardial ischemia/infarction, and drugs.
III
4. Know the physiology and pathophysiology of the atrioventricular conduction system and the types and
associated clinical manifestations of accessory pathways.
III
5. Know the genetic basis of arrhythmias, including genetically-based ion channel abnormalities and inherited
cardiomyopathies.
III
6. Know the epidemiology of arrhythmias. III
7. Know the inﬂuence of acquired structural or congenital heart disease in causing cardiac arrhythmias and its effect on
clinical decision-making about arrhythmia risk and management.
III
8. Know the systemic disorders and metabolic abnormalities associated with arrhythmias and conduction abnormalities. III
Diagnostic Tests
Noninvasive Diagnostic Tests
9. Know the role and method of interpreting ECGs obtained during sinus rhythm, exercise, and cardiac arrhythmias
in the evaluation of patients with known or suspected cardiac arrhythmias.
III
10. Know the methods to interpret surface ECG for the differential diagnosis of cardiac arrhythmias. III
11. Know the indications for event monitors/recorders and Holter monitors/recorders and the methods to interpret the results. III
12. Know the indications for tilt table tests, the methods to perform a tilt table test, and the methods to interpret the results. III
13. Know the role of exercise stress testing, with or without imaging, in the evaluation and management of patients with
cardiac arrhythmias.
III
14. Know the role of transthoracic and transesophageal echocardiography in the management of patients with cardiac
arrhythmias.
III
15. Know the role of transesophageal echocardiography and intracardiac echocardiography in guiding trans-septal
puncture and ablation near key anatomic structures and monitoring for the development of a pericardial effusion.
III
16. Know the role of advanced imaging (computed tomography, magnetic resonance imaging, and positron emission
tomography) in the evaluation and management of patients with cardiac arrhythmias.
III
17. Know the electrophysiological basis of various electrocardiographic parameters such as signal-averaged
electrocardiography.
III
18. Know the methods to interpret tracings and other information downloaded from pacemakers, deﬁbrillators, and
implanted loop monitors with respect to both arrhythmias and heart failure management.
III
19. Know the indications for referring patients for sleep apnea evaluation. III
Invasive Electrophysiological Testing
20. Know the techniques of, indications for, contraindications, and potential complications of invasive electrophysiological
studies.
III
21. Know the principles of obtaining vascular access, multielectrode catheter placement, electrogram recording, and
stimulation.
III
22. Know the invasive laboratory recording techniques, including the principles of ampliﬁers, ﬁlters, and signal processors. III
23. Know the principles of advanced 3-dimensional mapping systems, including anatomical chamber reconstruction, image
integration, and creation and interpretation of electroanatomical activation and voltage maps.
III
24. Know the principles of radiation safety and of electrical safety (related to ﬂuoroscopy and other equipment used
in the laboratory) in the performance of electrophysiology studies, ablation, or device therapy.
III
25. Know the characteristics of unipolar and bipolar intracardiac electrocardiographic signals. III
26. Know the methods of programmed electrical stimulation, the role of provocative drug testing/stimulation, and the
characteristic ﬁndings in patients with and without arrhythmias or conduction disturbances.
III
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TABLE 1 Continued
Competency Component Milestones (Months)
MEDICAL KNOWLEDGE 12 24 Add
27. Know the pacing protocols to evaluate sinus node and atrioventricular node function and to induce supraventricular
and ventricular arrhythmias, including use of entrainment.
III
28. Know the predictive value and limitations of invasive electrophysiological studies in patients with various arrhythmias
and clinical syndromes.
III
Nondevice Therapies
Antiarrhythmic Medications
29. Know the indications, contraindications, and clinical pharmacology of antiarrhythmic drugs and sympathetic and
parasympathetic agonists and antagonists.
III
30. Know the clinical pharmacokinetics and pharmacodynamics of antiarrhythmic medications. III
31. Know the adverse effects of antiarrhythmic drugs, including drug–drug and drug–device interactions and
proarrhythmia potential.
III
Catheter Ablation
32. Know the biophysics of radiofrequency, cryoablation, and other ablation energy sources that become available. III
33. Know the indications and contraindications for catheter ablation of all types of cardiac arrhythmias. III
34. Know the complications associated with catheter ablation of all types of cardiac arrhythmias. III
35. Know the methods to minimize the risks of complications of catheter ablation. III
36. Know the methods to manage complications that occur during catheter ablation. III
37. Know the relative beneﬁts and risks associated with radiofrequency ablation, cryoablation, and other ablation
technologies that become available.
III
Surgical Ablation
38. Know the pathophysiological basis of arrhythmia surgery. III
39. Know the techniques, indications for, and complications associated with surgical treatment of cardiac arrhythmias,
including surgical atrial ﬁbrillation ablation.
III
Implantable Devices
Pacemakers
40. Know the indications for implantation of a cardiac pacemaker and the methods to select the appropriate pacemaker
type for a particular patient.
III
41. Know the complications associated with placement of a cardiac pacemaker and the methods to manage those
complications.
III
42. Know the methods to interrogate, program, and troubleshoot cardiac pacemakers, including the use of remote
monitoring and interrogation.
III
Implantable Deﬁbrillators
43. Know the indications for implantation of an implantable cardioverter-deﬁbrillator for primary and secondary
prevention of sudden cardiac death.
III
44. Know the methods for selecting the appropriate implantable cardioverter-deﬁbrillator type (including subcutaneous
implantable cardioverter-deﬁbrillators) for a particular patient.
III
45. Know the complications associated with implantation of an implantable cardioverter-deﬁbrillator and the methods to
manage them.
III
46. Know the methods to interrogate, program, and troubleshoot implantable cardioverter-deﬁbrillators including the
use of remote interrogation.
III
Resynchronization Therapy
47. Know the indications for cardiac resynchronization therapy. III
48. Know the complications associated with placement of a cardiac resynchronization therapy device and the methods to
manage those complications.
III
49. Know the theories and methodology of optimization of cardiac resynchronization therapy as well as the methods to
interrogate, program, and troubleshoot cardiac resynchronization therapy.
III
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TABLE 1 Continued
Competency Component Milestones (Months)
MEDICAL KNOWLEDGE 12 24 Add
Implantable Loop Monitors
50. Know the indications for and complications of implantable loop monitors and the methods to interpret the recordings. III
Left Atrial Appendage Occlusion/Ligation
51. Know the indications for left atrial appendage occlusion and appendage ligation. III
52. Know the techniques of and complications associated with left atrial appendage occlusion and appendage ligation. III
53. Know the methods to manage the complications associated with left atrial appendage occlusion and appendage ligation. III
Lead Management
54. Know the indications for lead extraction and management strategies for infected devices. III
55. Know the complications of lead extraction and the methods to manage them. III
56. Know the methods for diagnosing and managing lead failure. III
Arrhythmia Types and Syndromes
Bradyarrhythmias and Heart Block
57. Know the pathophysiological basis of sinus node dysfunction and heart block. III
58. Know the differential diagnosis and approach to diagnosis of patients with heart block, acquired and congenital. III
59. Know the methods to diagnose and manage sinus node dysfunction and heart block, acquired and congenital. III
Atrial Fibrillation and Atrial Flutter
60. Know the pathophysiological basis of atrial ﬁbrillation and atrial ﬂutter. III
61. Know the methods to diagnose atrial ﬁbrillation and atrial ﬂutter. III
62. Know the methods to assess the risk of stroke and bleeding in patients with atrial ﬁbrillation and atrial ﬂutter. III
63. Know the indications for, complications of, and contraindications to anticoagulation. III
64. Know the pharmacology of anticoagulant drugs, including reversal of actions. III
65. Know when and how to prescribe and monitor anticoagulant drugs. III
66. Know when and how to prescribe rate control medications. III
67. Know when to recommend ablation of the atrioventricular node for rate control. III
68. Know when and how to prescribe antiarrhythmic medications for rhythm control strategies. III
69. Know the indications and techniques for electrical and pharmacological cardioversion. III
70. Know the techniques, risks, and beneﬁts of catheter and surgical ablation of atrial ﬁbrillation and atrial ﬂutter. III
71. Know the methods to manage the complications associated with catheter ablation of atrial ﬁbrillation and atrial ﬂutter. III
Other Supraventricular Tachycardias
72. Know the pathophysiological basis of atrial tachycardia, junctional tachycardia, atrioventricular nodal re-entrant
tachycardia, and accessory pathway-mediated tachycardia and associated risks of each arrhythmia, including sudden
cardiac death, heart failure, and stroke.
III
73. Know the methods to stratify risk of sudden death in patients with pre-excitation. III
74. Know the methods to diagnose atrial tachycardia, junctional tachycardia, atrioventricular nodal re-entrant tachycardia,
and accessory pathway-mediated tachycardia.
III
75. Know when and the methods to recommend drug therapy for patients with atrial tachycardia, junctional tachycardia,
atrioventricular nodal re-entrant tachycardia, and accessory pathway-mediated tachycardia.
III
76. Know the indications for, techniques of, and complications associated with catheter ablation for treatment of patients
with atrial tachycardia, junctional tachycardia, atrioventricular nodal re-entrant tachycardia, and accessory pathway-
mediated tachycardia.
III
77. Know the methods to manage the complications associated with catheter ablation of atrial tachycardia, junctional
tachycardia, atrioventricular nodal re-entrant tachycardia, and accessory pathways.
III
Inherited Arrhythmia Syndromes and Genetic Testing
78. Know the pathophysiological basis of arrhythmias that occur in patients with an inherited arrhythmia syndrome/
cardiomyopathy.
III
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TABLE 1 Continued
Competency Component Milestones (Months)
MEDICAL KNOWLEDGE 12 24 Add
79. Know the genetic basis of inherited arrhythmia syndromes/cardiomyopathy. III
80. Know the methods to diagnose inherited arrhythmia syndromes/cardiomyopathy, including the roles and limitations of
genetic testing in diagnosis and family screening.
III
81. Know the methods to manage patients with inherited arrhythmia syndromes. III
82. Know the indications for pharmacotherapy, ablation, cardiac sympathetic denervation, and device therapy for the
treatment of patients with an inherited arrhythmia syndrome/cardiomyopathy.
III
Ventricular Arrhythmias and Sudden Cardiac Death
83. Know the deﬁnition and magnitude of the problem of sudden cardiac arrest/death, the methods to manage acute
episodes, and the methods to evaluate and treat survivors.
III
84. Know the pathophysiological basis of ventricular arrhythmias, including premature ventricular contractions,
nonsustained ventricular tachycardia, torsades de pointes, sustained ventricular tachycardia, ventricular ﬁbrillation,
pulseless electrical activity, and heart block/asystole.
III
85. Know the pathophysiological basis of and the acute and long-term approach to management of patients with aborted
sudden cardiac death.
III
86. Know the methods of diagnosing and managing patients with premature ventricular contractions, nonsustained
ventricular tachycardia, torsades de pointes, ventricular tachycardia, ventricular ﬁbrillation, pulseless electrical
activity, and heart block/asystole.
III
87. Know when and the methods to recommend drug therapy for patients with ventricular arrhythmias. III
88. Know the indications and techniques for electrical and pharmacological cardioversion and deﬁbrillation. III
89. Know the indications for, techniques for, and complications associated with catheter ablation of ventricular arrhythmias. III
90. Know the methods for determining sudden cardiac death risk and when to advise implantation of an implantable
cardioverter-deﬁbrillator in patients with or at risk for development of ventricular arrhythmias.
III
91. Know the methods to assess sudden death risk in athletes. III
92. Know the methods to diagnose and manage ventricular arrhythmias in athletes. III
Syncope
93. Know the differential diagnosis of syncope. III
94. Know the methods for determining the cause of syncope, including the role of the clinical history, ECG, noninvasive
arrhythmia monitoring, cardiac imaging, electrophysiology testing, and tilt table testing.
III
95. Know the methods for treating patients with syncope, including vasovagal syncope and syncope resulting from
cardiac arrhythmias.
III
Palpitations and Paroxysmal Supraventricular Tachycardias
96. Know the differential diagnosis of patients presenting with palpitations and the corresponding methods for diagnosis
and treatment.
III
97. Know the differential diagnosis of patients with paroxysmal supraventricular tachycardia and the corresponding
methods for diagnosis and treatment.
III
EVALUATION TOOLS: direct observation, chart-stimulated recall, multisource evaluation, and conference presentation.
PATIENT CARE AND PROCEDURAL SKILL 12 24 Add
Patient Consultation and Management
1. Skill to perform a comprehensive clinical evaluation (consultation) for patients with manifest or suspected cardiac
arrhythmias or conduction disturbance and to establish an appropriate evaluation and management plan in both
outpatient and inpatient settings.
III
2. Skill to evaluate and manage patients in the intensive care and postoperative electrophysiology procedural and
surgical care units.
III
Diagnostic Tests
Noninvasive Diagnostic Tests
3. Skill to appropriately utilize and perform noninvasive testing in the evaluation and management of patients with
arrhythmias.
III
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TABLE 1 Continued
PATIENT CARE AND PROCEDURAL SKILL 12 24 Add
4. Skill to appropriately utilize electrocardiography in the evaluation and management of patients with cardiac
arrhythmias and inherited arrhythmia syndromes.
III
5. Skill to appropriately utilize and perform exercise stress testing in the evaluation and management of patients with
arrhythmias.
III
6. Skill to appropriately utilize transthoracic and transesophageal echocardiography in the evaluation and management
of patients with arrhythmias.
III
7. Skill to appropriately utilize and perform intracardiac echocardiography in the evaluation and management of patients
with arrhythmias.
III
8. Skill to appropriately utilize advanced imaging (cardiovascular computed tomography, cardiovascular magnetic
resonance, and positron emission tomography) in the evaluation and management of cardiac arrhythmias.
III
Invasive Electrophysiological Evaluation
9. Skill to place sheaths in the femoral, internal jugular, subclavian, axillary, and cephalic veins using anatomic landmarks
and ultrasound imaging.
III
10. Skill to place sheaths in the femoral arteries using anatomic landmarks and ultrasound imaging. III
11. Skill to place and manipulate electrode catheters in the atria, ventricles, coronary sinus, His bundle area, aortic root,
and pulmonary artery.
III
12. Skill to accurately measure and assess conduction intervals and refractory periods during programmed electrical
stimulation.
III
13. Skill to use intracardiac recordings to determine activation sequence mapping and to interpret the responses to pacing
techniques including entrainment.
III
14. Skill to use advanced 3-dimensional mapping systems, including anatomical chamber reconstruction, image integration,
and electroanatomical activation and voltage maps in the management of patients with cardiac arrhythmias.
III
15. Skill to appropriately utilize and monitor sedation during procedures. III
16. Skill to identify patients in whom general anesthesia should or should not be considered for electrophysiology and
device procedures.
III
17. Skill to recognize and manage procedural complications, including vascular complications, cardiac perforation/
tamponade, pneumothorax, lead dislodgements, and pocket complications (e.g., bleeding, infection).
III
18. Skill to appropriately select patients for electrophysiology procedures and effectively carry out preprocedural,
intraprocedural, and postprocedural management and follow-up.
III
19. Skill to integrate the ﬁndings from invasive electrophysiological testing with clinical and other testing results in the
management of patients with arrhythmias or conduction disturbances.
III
20. Skill to apply diagnostic pacing maneuvers to distinguish among different forms of supraventricular tachycardia and in
assessment of ventricular tachycardia.
III
21. Skill to perform and interpret invasive electrophysiological testing in patients with all forms of arrhythmias, including
AV nodal re-entrant tachycardia, atrial tachycardia or ﬂutter, atrioventricular node or accessory pathway abnormalities,
and ventricular arrhythmias.
III
Nondevice Therapies
Antiarrhythmic Medications
22. Skill to prescribe antiarrhythmic drug therapy for treatment of patients with cardiac arrhythmias. III
23. Skill to monitor patients being treated with antiarrhythmic drug therapy. III
24. Skill to manage patients with a pro-arrhythmic response to antiarrhythmic drug therapy or side effects to
antiarrhythmic drugs.
III
Catheter Ablation
25. Skill to carry out ablation therapy in patients with atrioventricular nodal re-entrant tachycardia, atrial tachycardia,
typical atrial ﬂutter, and accessory pathway–mediated arrhythmias.
III
26. Skill to carry out ablation therapy in patients with atrial ﬁbrillation. III
27. Skill to carry out ablation therapy in patients with atypical atrial ﬂutter. III
28. Skill to carry out ablation therapy in patients with idiopathic premature ventricular contractions and/or ventricular
tachycardia arising from right ventricular outﬂow tract.
III
29. Skill to carry out ablation therapy in patients with idiopathic premature ventricular contractions and/or ventricular III
Competency Component Milestones (Months)
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TABLE 1 Continued
PATIENT CARE AND PROCEDURAL SKILL 12 24 Add
30. Skill to identify appropriate candidates for and assess risk/beneﬁt of epicardial approach to ventricular tachycardia
ablation.
III
31. Skill to carry out epicardial ventricular tachycardia ablation. III
32. Skill to introduce sheaths and catheters into the left atrium via a patent foramen ovale or trans-septal puncture to
perform mapping and ablation.
III
33. Skill to access the aortic root and/or left ventricle using a retrograde aortic approach. III
34. Skill to utilize magnetic resonance imaging, computed tomography, and intracardiac echocardiography to facilitate
invasive electrophysiology testing, intracardiac mapping, and catheter ablation.
III
35. Skill to effectively perform ablation for scar-based atrial and ventricular arrhythmias. III
36. Skill to perform invasive electrophysiology studies and ablation therapy in adult patients with repaired or unrepaired
congenital heart disease.
III*
37. Skill to recognize and manage patients who experience a complication during and/or following catheter ablation. III
38. Skill to minimize the risks of complications associated with catheter ablation. III
Surgical Ablation
39. Skill to identify patients likely to beneﬁt from surgical treatment of cardiac arrhythmias. III
40. Skill to follow patients who have undergone surgical treatment of a cardiac arrhythmia. III
Implantable Devices
Pacemakers
41. Skill to appropriately select, implant, test, interrogate, program, and follow pacemakers. III
42. Skill to identify and manage complications associated with pacemaker implantation. III
Implantable Cardioverter-Deﬁbrillators
43. Skill to appropriately select, implant, test, interrogate, program, and follow implantable cardioverter-deﬁbrillator
devices in clinic and remotely.
III
44. Skill to identify and manage complications associated with placement of implantable cardioverter-deﬁbrillators. III
45. Skill to identify appropriate patients for, and to implant, subcutaneous implantable cardioverter-deﬁbrillators. III
Resynchronization Therapy
46. Skill to appropriately select, implant, test, interrogate, program, and follow cardiac resynchronization therapy devices. III
47. Skill to identify and manage complications associated with cardiac resynchronization therapy device implantation. III
Implantable Loop Recorders
48. Skill to implant implantable loop recorders. III
49. Skill to interrogate and follow patients who have undergone implantable loop recorder implantation. III
Left Atrial Appendage Occlusion/Ligation
50. Skill to perform placement of a left atrial appendage occlusion device, including recognition and management of
complications.
III*
51. Skill to perform left atrial appendage ligation using a percutaneous approach, including recognition and management
of complications.
III*
52. Skill to identify patients who are candidates for surgical left atrial appendage ligation and to follow these patients
following the procedure.
III
Lead Management
53. Skill to identify anatomic lead location on the basis of ﬂuoroscopic or x-ray image. III
54. Skill to perform lead extraction. III*
55. Skill to manage patients with lead failure. III
56. Skill to manage patients with a device infection. III
Arrhythmia Types and Syndromes
Bradyarrhythmias and Atrioventricular Block
57. Skill to diagnose and manage patients with bradyarrhythmias, including sinus node dysfunction, asystole, and heart block. III
Competency Component Milestones (Months)
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TABLE 1 Continued
PATIENT CARE AND PROCEDURAL SKILL 12 24 Add
Atrial ﬁbrillation and Atrial Flutter
58. Skill to diagnose and manage patients with atrial ﬁbrillation, including anticoagulation and rate and rhythm control. III
59. Skill to perform electrical and pharmacological cardioversion. III
Other Supraventricular Arrhythmias
60. Skill to diagnose and manage patients with supraventricular tachycardia, including with pharmacological therapy and
catheter ablation.
III
Inherited Arrhythmia Syndromes and Genetic Testing
61. Skill to diagnose, manage, or refer patients with an inherited arrhythmia syndrome/cardiomyopathy to physicians/
programs who have this expertise.
III
62. Skill to know when to order genetic testing. III
63. Skill to interpret the results of genetic testing with the assistance of a genetic counselor. III
Ventricular Arrhythmias and Sudden Cardiac Death
64. Skill to evaluate and manage patients at risk for sudden cardiac arrest or aborted sudden cardiac arrest. III
65. Skill to evaluate and manage patients with ventricular arrhythmias, including premature ventricular contractions,
nonsustained ventricular tachycardia, torsades de pointes, sustained ventricular tachycardia, and ventricular ﬁbrillation.
III
66. Skill to perform electrical and pharmacological cardioversion and deﬁbrillation. III
Syncope
67. Skill to evaluate and manage patients with syncope. III
Palpitations and Paroxysmal Supraventricular Tachycardias
68. Skill to evaluate and manage patients with palpitations and paroxysmal supraventricular tachycardia. III
EVALUATION TOOLS: chart-stimulated recall, clinical and patient safety and quality improvement conference presentation, direct observation,
multisource evaluation, and logbook, simulation.
SYSTEMS-BASED PRACTICE 12 24 Add
1. Use hospital data and available registries to assess appropriateness, performance, and safety of implanted devices. III
2. Work effectively with hospital electrophysiology laboratory staff to enhance safety and efﬁciency while controlling cost. III
3. Incorporate risk/beneﬁt analysis and cost considerations in diagnostic and treatment decisions. III
4. Work as part of a multidisciplinary team to provide safe and effective transitions of care within and across healthcare
systems.
III
EVALUATION TOOLS: chart-stimulated recall, direct observation, and multisource evaluation.
PRACTICE-BASED LEARNING AND IMPROVEMENT 12 24 Add
1. Identify knowledge and performance gaps and engage in opportunities to achieve focused education and performance
improvement.
III
2. Know how to conduct literature searches and apply results to clinical care. III
3. Develop practice of lifelong learning, including regular review of cardiology and clinical cardiac electrophysiology
journals and attending appropriate scholarly meetings.
III
4. Learn and improve via feedback and performance audit. III
EVALUATION TOOLS: chart-stimulated recall, conference presentation, logbook, and self-reﬂection.
Competency Component Milestones (Months)
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TABLE 1 Continued
PROFESSIONALISM 12 24 Add
1. Practice within the scope of personal expertise and technical skills. III
2. Demonstrate sensitivity to patient preferences and end-of-life decisions. III
3. Accept responsibility and follow through on tasks. III
EVALUATION TOOLS: chart-stimulated recall, conference presentation, direct observation, and self-reﬂection.
INTERPERSONAL AND COMMUNICATION SKILLS 12 24 Add
1. Communicate effectively with patients, families, and interprofessional teams across a broad range of cultural, ethnic,
and socioeconomic backgrounds including those from underserved communities.
III
2. Engage in shared decision-making with patients, including options for diagnosis and treatment. III
3. Provide test results and interpretations to healthcare providers and patients in a timely fashion. III
EVALUATION TOOLS: direct observation and multisource evaluation.
Add indicates additional training beyond the standard 2-year CCEP fellowship and ECG, electrocardiogram. *Given the complex and highly skilled nature of these competencies,
additional focused training and experience is required either during or following the 2-year CCEP fellowship.
Competency Component Milestones (Months)
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2782each domain. It is expected that all trainees will achieve
the Level III competencies listed in the table. In addition,
selected Level III competency components designated
with an asterisk (i.e., “III*”) require additional training
beyond the requirements for every trainee. These addi-
tional competencies may be obtained during or after the
standard CCEP fellowship, depending on the trainee’s
career focus and the training opportunities available at
the trainee’s CCEP fellowship program. It is recognized
that not all CCEP programs have sufﬁcient volume of lead
extraction and/or epicardial VT ablation procedures, for
example, to adequately train $1 CCEP trainee in these
skills within a 24-month fellowship. The milestone
interval (12 months, 24 months, or additional months)
indicates the stage by which the typical trainee will ach-
ieve a particular competency. In recognition of the fact
that programs may vary with respect to the sequence of
clinical experiences provided to trainees, the time at
which various competencies are achieved may also
vary. Moreover, although the competency components
included in this table should be achieved by all trainees
and are appropriate areas for assessment, not every
component need be individually assessed in every
trainee. Rather, as with all educational activities, assess-
ment is a sampling process that should be tailored to the
needs of the individual trainee and program.
4.2. Number of Procedures and Duration of Training
The minimum number of interventional procedures
recommended for the 2-year Level III CCEP fellowship
training is the consensus formed by review and
consideration of published literature applicable to this
topic (12–18), previously published competencystatements (19,20), COCATS (10,21,22), policies of the
ACGME (6) and the ABIM (23), results from a 2015 survey
of CCEP training program directors, practice guidelines
(24–27), expert consensus documents (28–32), a policy
statement (33) relevant to the practice regarding in-
dications and contraindications of these procedures, and
the experience and opinions of the members of the
writing group. Recommended procedural numbers are
summarized in Table 2. The previously published pro-
cedural numbers from the American training documents
(6,10,19–23,34) and from international societies and or-
ganizations are summarized in Table 3 (35–37). It is ex-
pected that the training is directed by an appropriately
trained and board-certiﬁed mentor in an ACGME–
accredited program as deﬁned in Section 2.1. The satis-
factory completion of such training is documented by
the program director.
As indicated in Section 1.2.3, the procedural volumes in
this document are based on a judgment about the mini-
mum experience required to provide most trainees with a
sufﬁcient variety of clinical situations and to allow faculty
enough opportunity to evaluate the trainee’s emerging
competency. The numbers of procedures necessary to
achieve competence should be interpreted as approxi-
mate, based on the educational needs and progress of
typical trainees in typical programs. Proﬁciency and out-
comes, rather than length of exposure or the exact num-
ber of procedures performed, are the dominant criteria for
evaluation of competency in the context of educational
milestones. In addition, absolute mastery of all aspects of
EP is not likely to be achieved on the basis of the
fellowship experience alone. For common and straight-
forward procedures, mastery can occur, but for very
TABLE 2
Recommendations for Minimum
Procedural Volume to Achieve and
Demonstrate Competence in
Clinical Cardiac Electrophysiology
Procedures Numbers*
Diagnostic electrophysiology studies
(which can be performed with catheter ablation procedures)
175
Catheter ablation procedures 160
SVT (not including atrial ﬁbrillation or ﬂutter) 50
Focal AT 5
AVN 5
AVNRT 25
AVRT/AP 15
Atrial ﬂutter/macro–re-entrant AT 30
Isthmus dependent atrial ﬂutter 20
Nonisthmus dependent/complex macro–re-entry
atrial arrhythmias
10
Atrial ﬁbrillation 50
VT/PVC ablation 30
Idiopathic VT/PVCs 20
VT/PVCs in patients with SHD 10
CIED procedures
CIED implantation 100
Pacemakers 40†
ICDs 60†
CRT pacemakers or ICDs 25‡
CIED replacement/revision 30
CIED interrogation/programming 200
CIED interrogation/programming, pacemakers 100
CIED interrogation/programming, ICDs 100
Remote device interpretation§ 50
Lead extraction proceduresk
(with one or more leads implanted >12 months previously)
30
Tilt table tests 5
*Actual numbers that should be performed and/or interpreted successfully to achieve
competence are intended as general guidance, based on the educational needs and
progress of typical CCEP trainees. †Of which at least 20 should be dual chamber. ‡Also
count as pacemaker or implantable cardioverter-deﬁbrillator implants. §The remote
interrogations can be included as CIED interrogation/programming number re-
quirements. kLead extraction is a special competency not expected of all CCEP trainees.
AP indicates accessory pathway; AT, atrial tachycardia; AVN, atrioventricular node;
AVNRT, atrioventricular nodal re-entrant tachycardia; AVRT, atrioventricular recipro-
cating tachycardia; CIED, cardiac implantable electrical device; CRT, cardiac resynch-
ronization therapy; ICD, implantable cardioverter-deﬁbrillator; PVC, premature
ventricular contraction; SHD, structural heart disease; SVT, supraventricular tachy-
cardia; and VT, ventricular tachycardia.
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2783complex or infrequently-performed procedures, lower
levels of proﬁciency are anticipated for new graduates.
Realistically, full proﬁciency in advanced techniques may
develop only after additional years of experience, as
indicated in Table 1.
Signiﬁcant overlap exists in the rapidly growing ﬁelds
of interventional EP and CIED procedures; however, there
are differences in the acquisition of technical abilities
and cognitive skills with respect to different types ofarrhythmias and diagnostic and therapeutic inter-
ventions. For instance, the technical skills needed for
ablation of AF are substantial. These include performance
of trans-septal puncture and cannulation of the left
atrium; precise manipulation of the catheter for mapping
and ablation; identiﬁcation of the pulmonary vein ostia;
adjustment of the energy used for ablation; and the
appropriate use of ﬂuoroscopy, radiographic contrast
imaging, 3-dimensional mapping systems, and/or intra-
cardiac echocardiography. Concepts related to pacing
maneuvers and entrainment are especially important for
characterizing the mechanisms of supraventricular ar-
rhythmias or VAs and for determining the point of origin,
the location of the AP, and/or the critical zone of con-
duction. All are important to the success of ablation.
CIEDs share many common implantation techniques and
requisite knowledge for management; however, deﬁbril-
lation and antitachycardia pacing testing, cannulation of
the coronary sinus for CRT, lead extraction for defective
or infected devices, or programming and management of
pacemakers versus ICDs requires different skills. Training
programs vary in expertise, technology available, and
procedural volumes; nevertheless, trainees are expected
to develop proﬁciencies and be well-versed in most
EP–related interventional procedures upon completion
of a 2-year fellowship. For these reasons, the recom-
mendations for procedural numbers are categorized by
supraventricular tachycardia (SVT), atrial ﬂutter and
macro–re-entrant AT, AF, VA, CIED implantation, CIED
interrogation and programming, and lead extraction. It is
recognized that not all trainees will receive training in
all aspects of clinical EP and device implantation and
management. The core components of EP training that
are required of all trainees, as well as those compo-
nents of EP training that are considered elective and, as
a result, are not required to complete a CCEP training
program, are presented in Table 1. The proﬁciencies
that are not required for all CCEP trainees include
epicardial VT ablation, lead extraction, atrial appendage
occlusion/ligation, and catheter ablation of atrial ar-
rhythmias and VAs in patients with complex congenital
heart disease.
Each trainee should perform at least 175 electrophysi-
ological procedures for arrhythmia evaluation. These can
be performed in conjunction with catheter ablation pro-
cedures. Over the 2-year CCEP fellowship, at least 160
ablation procedures should be performed, with at least 50
of these being supraventricular ablation procedures.
These ablations should include 5 focal ATs, 5 AV node
ablations, 25 AV nodal re-entrant tachycardias, and 15 AV
re-entrant tachycardias and other less common SVTs,
including sinus node re-entrant tachycardia and junc-
tional tachycardia. The role of the trainee should either be
to function as the primary hands-on operator or to
TABLE 3 History of Societal Recommendations for Training to Achieve Competence in Clinical Cardiac Electrophysiology
Source
CCEP Procedures, n
EP
Studies*
SVT
Ablation
Atrial
Flutter/
Macro–
Re-Entrant
AT
Atrial
Fibrillation
Ventricular
Arrhythmia
CIED
Interrogation/
Programming
CIED
Implantation Pacemaker ICD CRT
CIED
Replacement/
Revision
Lead
Extraction
ACP/ACC/
AHA
1994
(19)
100 NS NS NS NS NS NS NS NS NS NS NS
ACC/AHA
2006
(20)
150 50–75 NS 30–50 NS NS NS NS NS NS NS NS
COCATS
1995
(21)
100 50 NS NS NS NS 50 NS NS NS NS NS
COCATS
2008
(10)
150 75 NS 30–50 NS 200 75† 25 25 25 30 20
ACGME
2016
(6)
150–175 75 NS NS NS NS NS 25‡ 25 25 NS NS
ABIM 2014
(23)
150 75 NS NS NS NS 25 NS NS NS NS NS
British
Cardiac
Society
1995
(35)
70 50 NS NS NS NS NS NS NS NS NS NS
CCS/CHRS
2011
(37)
100–150 50 10–20§ 30–50 10–20k NS 75 NS 25 15 20 NS
EHRA
2009
(36)¶
200 (50) 150 (35) NS NS NS NS NS 50 (30) 30 (15) 20 (10) NS NS
*Including ablation. †25 dual-chamber CIEDs are required. ‡Dual chamber. §Macro–re-entrant AT. kScar-dependent. ¶Total procedures (as the primary operator).
ABIM indicates American Board of Internal Medicine; ACC, American College of Cardiology; ACGME, Accreditation Commission for Graduate Medical Education; ACP, American
College of Physicians; AHA, American Heart Association; CCS, Canadian Cardiovascular Society; CHRS, Canadian Heart Rhythm Society; COCATS, Core Cardiovascular Training
Statement; EHRA, European Heart Rhythm Association; EP, electrophysiology; ICD, implantable cardioverter-deﬁbrillator; n, number; NS, not speciﬁed; other abbreviations as in
Table 2.
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2784perform programmed electrical stimulation and analyze
the diagnostic components of the procedure. Expertise in
catheter placement, programmed electrical stimulation,
endocardial mapping, catheter ablation, and interpreta-
tion of data must be ensured by the CCEP faculty and
training program director. The endocardial mapping
experience should include left heart mapping by either
the retrograde aortic or trans-septal approach for APs.
Training in trans-septal catheterization for performance
of AF ablation and for ablation of arrhythmias originating
from the left atrium or involving left APs is required.
These numbers should not be regarded as strict re-
quirements but rather as a general framework of the
depth and breadth of exposure that trainees should obtain
during their training. Earlier data from multicenter sur-
veys suggest that procedural complications were signiﬁ-
cantly associated with procedural volumes. From the
Multicenter European Radiofrequency Survey (15),
complication rates of 4.6% were reported from centerswith $100 cases/year, compared with 5.6% from centers
performing #50 cases/year. From a 1994 survey from the
North American Society of Pacing and Electrophysiology
(14), a 1.5% complication rate was reported from centers
performing $50 cases/year, whereas complications
occurred in 3.2% of patients from centers performing #20
cases/year. The success rate of AP ablation was related
to the operator’s experience.
The patient population with typical atrial ﬂutter and
other macro–re-entrant AT is growing, primarily related to
increasing surgical and ablation procedures in the atria.
Each trainee should participate in mapping and ablation
of at least 30 of these arrhythmias. Achieving competence
in programmed electrical stimulation with cognitive skills
in identifying the arrhythmia circuit using both activation
and entrainment mapping, determining appropriate sites
for ablation, and demonstrating conduction block across
re-entry circuit sites post-ablation is expected. Integra-
tion of knowledge related to 3-dimensional mapping
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2785systems and re-entrant mechanisms is required. Although
it is unlikely that trainees will be exposed to all mapping
technologies during their 2 years of training given the
rapid evolution of new mapping technologies, trainees
should be exposed to tools for deﬁnition of intracardiac
anatomy, such as intravascular ultrasound, CMR, CT, and
advanced mapping systems. Of the 30 procedures, at least
20 typical atrial ﬂutters and 10 other macro–re-entrant
ATs are expected. It is anticipated that postgraduate
education will continue after the 2 training years.
AF ablation is the most commonly performed catheter
ablation procedure today. The procedure is complex,
requiring technical ability and dexterity, an in-depth
understanding of anatomical relationships, and integra-
tion of cognitive skills. Each trainee should participate
in at least 50 AF ablation cases. Although the standardi-
zation of the technical approach continues to evolve
(25,26,31), improved outcomes have been associated with
centers that perform at least 100 ablation procedures
annually (12,16–18). Complications are also related to
procedural volumes. Data from the National Inpatient
Sample (13) showed that procedural complication rates
were signiﬁcantly lower among operators performing $50
AF ablations/year compared with #25 cases/year. Lower
complication rates occurred in hospitals that performed
at least 100 cases/year compared with those that
performed <50 cases/year.
Fellowship training on ablation of VAs is important.
Each trainee should participate in at least 30 ablation
procedures for VA. Ablation of VAs requires a wide spec-
trum of technical skills and understanding of anatomy, as
it may require mapping of right ventricular and left ven-
tricular endocardium, the great vessels including the
aortic root and venous structures, and/or the epicardium.
The substrate for re-entrant VT occurs in both ischemic
heart disease and nonischemic heart disease. Due to the
wide spectrum of VA location and substrate, it is recom-
mended that experience should include 20 VAs of the
idiopathic type and 10 VAs in patients with structural
heart disease. In addition to developing expertise in
electroanatomic mapping, fellows must have exposure
to the advanced ablation delivery systems. Due to the
thickness of the ventricular myocardium, technical pro-
ﬁciency in accessing epicardial space and positioning
catheters in cardiac venous vasculature is of value in
selected cases. Becoming expert in these evolving tech-
niques is not required of all EP trainees and, if desired,
may necessitate that the trainee obtain additional training
in centers specializing in these procedures.
CIED training must include development of expertise
in permanent atrial and right and left ventricular pace-
maker lead placement and ICD lead placement, threshold
testing and programming of devices, understanding of
CIED infections, and management of implant-relatedcomplications. Individuals receiving qualifying training
in CIED implantation must participate as the primary
operator (under direct supervision) in at least 100 CIED
initial primary implantations, of which 25 should be
CRT device implantations. Primary implantations should
include at least 40 pacemakers (20 dual chamber), 60 ICDs
(20 dual chamber), and 25 CRT devices (either pacing or
deﬁbrillation). Thirty CIED revisions or replacements are
also required. The trainee must also participate in the
follow-up of at least 200 CIED patient visits and acquire
proﬁciency in advanced CIED electrocardiography, inter-
rogation, and device programming. Of the follow-up
visits, at least 100 should be in ICD and 100 in pace-
maker patients. Interpretation of at least 50 remote
device monitoring recordings is required. As part of the
training regarding CIEDs, exposure to the indications,
implantation techniques, and follow-up of loop recorders
is desirable.
CIED lead extraction is a specialized procedure that
requires special training. Physicians being trained in lead
extraction should perform at least 30 lead extraction
procedures under the direct supervision of a skilled and
experienced physician in this procedure. Each of these
30 procedures should involve removal of $1 lead that
had been implanted for 12 months or longer.
Tilt table testing is useful for the evaluation of syncope
and for the understanding of the physiology or patho-
physiology of vasovagal response and orthostatic intol-
erance. During the CCEP fellowship, a trainee should
conduct at least 5 tilt table tests.4.3. Diagnostic Testing
4.3.1. Noninvasive Diagnostic Tests
Numerous tests are available to evaluate the electro-
physiological properties of the heart. Although learning
the fundamentals of ECG is part of the basic knowledge
requirements for general cardiology, promulgating a
deeper understanding of the electrophysiological funda-
mentals that are manifest in ECG recordings is critical in
electrophysiological training. A series of professional
multisocietal documents provides information on stan-
dardized interpretation and reporting of the surface
12-lead ECG (38–43). Similarly, although evaluation of
ambulatory ECG monitoring is part of the basic cardiology
curriculum, a more nuanced interpretation is a critical
skill for electrophysiologists and often provides insight
into arrhythmia mechanism. For certain groups, such
as athletes, additional and more focused electrocardio-
graphic education and knowledge are required. Ambula-
tory ECGmonitoring techniques have evolved rapidly over
the past decade, and the electrophysiologist must under-
stand the relative beneﬁts of different monitoring tech-
nologies with particular focus on the cost, beneﬁt, and
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Some specialized tests including the signal-averaged ECG,
T-wave alternans, body surface mapping, tilt table testing,
and autonomic testing may not be in widespread clinical
use. However, understanding the electrophysiological
basis for these tests remains an essential component of EP
training, particularly in estimating the risk of sudden
cardiac arrest/death in selected patients (44–46).
Tilt table testing and treadmill testing can provide
valuable information for patients with orthostatic or
exercise-related symptoms or arrhythmias. In addition to
provocative tests designed to evaluate electrophysiolog-
ical properties of the heart in different conditions, EP
training must include a discussion of the full range of
cardiovascular stress testing techniques. For example,
stress testing used to identify the presence of signiﬁcant
coronary artery disease is often important for evaluating
the relationship between ischemia and arrhythmia
development in individual patients. Stress testing is also
important in determining the presence of exercise-related
arrhythmias.
Finally, noninvasive tests that allow imaging of the
heart have emerged as a critically important component
of EP training because of the close relationship between
cardiac anatomy and electrophysiological abnormalities.
An understanding of the application of techniques such
as echocardiography (transthoracic, transesophageal,
and intracardiac), cardiovascular CT, CMR imaging,
and nuclear studies in the setting of arrhythmias is
essential.
4.3.2. Invasive Electrophysiological Evaluation
Understanding the indications, risks, and performance of
invasive EP studies is a fundamental aspect of advanced
training in EP. The CCEP trainee should be able to
describe the indications for invasive EP evaluation,
perform and interpret a comprehensive EP study, create
and interpret an electroanatomic map, and integrate
these ﬁndings into a formal diagnosis and treatment plan
including an ablation strategy when indicated. This in-
cludes basic knowledge of recording techniques such as
principles of ampliﬁers, ﬁlters, signal processing, map-
ping techniques, and radiation safety. It also includes
the ability to independently perform the appropriate
selection of catheters; proper placement; mastery of
appropriate pacing protocols; and the ability to induce,
terminate, and evaluate the mechanisms of SVTs and VAs.
4.4. Arrhythmia Types and Syndromes
4.4.1. Pathophysiological Basis of Cardiac Arrhythmias/
Basic Electrophysiology
The “HRS Policy Statement: Clinical Cardiac Electro-
physiology Fellowship Curriculum: Update 2011” wasdeveloped by EP fellowship directors as a compendium of
the basic information necessary for the practicing elec-
trophysiologist (33). The curriculum recommended in this
document provides a useful framework for developing a
CCEP fellowship curriculum and emphasizes the impor-
tance of understanding basic EP (under both normal
conditions and disease states) and cardiac anatomy.
Important anatomic concepts identiﬁed by the document
include an understanding of anatomy of the heart with a
particular focus on tissues responsible for the normal
heart beat (the sinus node, AV node, His bundle and
branches), as well as an understanding of the anatomy of
the cardiac vascular system, great vessels, and autonomic
nervous system. Basic EP understanding requires
comprehensive knowledge of the resting membrane po-
tential and action potential for different cardiac tissues as
well as an understanding of the molecular, cellular, and
tissue basis for heart arrhythmias. In addition to knowl-
edge of arrhythmias in an individual patient, EP training
also requires an understanding of arrhythmias at a pop-
ulation level, including overall incidence and prevalence
and strategies that can be employed to treat arrhythmias
in groups of people.
As emphasized by Table 1, EP abnormalities can
develop in speciﬁc conditions such as genetic disorders,
congenital heart disease, metabolic abnormalities, and
systemic diseases. Competency in EP requires an under-
standing of arrhythmia issues that develop in these and
other conditions.
4.4.2. Inherited Arrhythmia Syndromes and Genetic Testing
Heart rhythm specialists are often involved in the initial
diagnosis of patients with inherited arrhythmia syndromes
and, in many cases, may manage patients with these con-
ditions longitudinally. The trainee must understand the
pathophysiological basis of arrhythmias that occur in pa-
tients with an inherited arrhythmia syndrome, the ECG
ﬁndings and other diagnostic features of the syndromes,
and the prognosis. The trainee should know the appro-
priate indication for and limitations of genetic testing and
family screening and be familiar with the role of genetic
counseling both prior to obtaining genetic tests and in
interpreting the test results. The trainee must know the
methods to manage these patients including: 1) risk strat-
iﬁcation for sudden cardiac death; 2) the indications, efﬁ-
cacy, and limitations of pharmacotherapy; 3) the role of
cardiac sympathetic denervation; 4) the indications for
device therapy; and 5) recommendation of activity levels,
exercise, and participation in competitive sports appro-
priate to the risks of the inherited disease state.
4.4.3. Bradyarrhythmias
Bradyarrhythmias can be broadly classiﬁed as those
resulting from abnormal automaticity (usually due to
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block. EP training should include instruction on the
epidemiology, natural history, etiology, anatomy, patho-
physiology, and treatment options for both sinus node
dysfunction and AV block. For sinus node dysfunction,
the different clinical manifestations (e.g., sinus pause or
exit block, bradycardia-tachycardia syndrome, chrono-
tropic incompetence), the strengths and limitations of
different diagnostic strategies (both invasive and nonin-
vasive), and appropriate use of pacing therapy must be
understood. Management of AV block requires an un-
derstanding of different clinical manifestations, diag-
nostic clues and strategies for identifying the anatomic
site of block (AV node versus infranodal), the importance
of associated conditions (e.g., the patient with AV block
due to sarcoidosis, the patient with AV block and neuro-
muscular disease), and appropriate use of CIED therapy
(single- versus dual-chamber pacing, special program-
ming algorithms to minimize ventricular pacing, CRT, and
deﬁbrillator capabilities).
4.4.4. Palpitations and Paroxysmal SVTs
Heart rhythm specialists are frequently involved in the
initial or ongoing diagnosis of individuals with unspeci-
ﬁed palpitations including suspected paroxysmal SVT.
Trainees should understand the differential diagnosis
of palpitations, including sustained versus nonsustained
arrhythmias, atrial arrhythmias versus VAs, and ar-
rhythmic versus nonarrhythmic etiologies. Trainees
should develop approaches for evaluating patients with
palpitations and suspected arrhythmias, including
appropriately selecting diagnostic modalities such as
ECG, ambulatory monitors, exercise stress testing, and EP
testing. Trainees should understand the indications for
treatment of palpitations and paroxysmal SVT at various
stages of diagnosis, including observation, lifestyle
modiﬁcation, medications, and catheter ablation.
4.4.5. Supraventricular Tachycardias
The trainee must understand the mechanisms and
methods of initiation of different SVTs including ATs, AV
nodal re-entrant tachycardia, AP-mediated tachycardias,
and junctional tachycardias. The trainee must be able to
perform and interpret pacing and mapping techniques
to differentiate various forms of SVT including pacing
maneuvers and interpretation of drug effects as well as
physical maneuvers. The trainee must also gain knowl-
edge in the role and selection of pharmacological therapy
to treat SVTs. Knowledge of the techniques, indications,
and risks of catheter ablation of SVT must also be ac-
quired. This includes experience with 3-dimensional
mapping techniques; techniques for retrograde and
trans-septal access; and understanding the underlyinganatomy, potential complications, and methods to avoid
complications.
4.4.6. AF and Atrial Flutter
Comprehensive knowledge of the epidemiology, anatomy,
and multifactorial pathophysiology of AF and atrial ﬂutter
is essential for CCEP training. It is now evident that pa-
tients with atrial arrhythmias represent a diverse group
with signiﬁcant differences in underlyingmechanisms and
symptoms. It is important that trainees understand the
relationship among sleep apnea, obesity, and AF as the
relationship concerns both etiology as well asmanagement
decisions. The electrophysiologist must have a clear un-
derstanding of the natural history of atrial arrhythmias;
potential consequences of increased risk for outcomes
such as stroke, dementia, cardiomyopathy, heart failure,
sudden death, and hospitalizations; and the likelihood of
1 of these adverse outcomes in an individual patient. In
particular, the trainee should be familiar with the
important and extensive evidence base for the associa-
tion of atrial arrhythmias and increased risk of stroke
and proven therapeutic strategies that can reduce
stroke risk in many patients. For oral anticoagulant
therapy, an understanding of the individual patient at
risk and the different mechanisms and pharmacology
of the speciﬁc agents that can reduce stroke risk is
essential. In addition, appropriate application of this
information to an individual patient is essential because
the electrophysiologist is often asked to provide a
nuanced opinion on best anticoagulant management in
difﬁcult cases in patients who are not well represented
in clinical trials.
Atrial arrhythmias can be treated with either a rate
control or rhythm control strategy (25). Electrophysiolo-
gists must have a comprehensive knowledge of the risks,
beneﬁts, and limitations of rate control and rhythm con-
trol strategies and be able to explain the risks, beneﬁts,
and alternatives to patients and their caregivers in a clear
and balanced manner. Initial and serial evaluation of AF
will often require diagnostic tests to evaluate arrhythmia
burden, adequacy of rate control, and identiﬁcation of
associated cardiac and noncardiac diseases or problems.
The best diagnostic strategy often varies from patient to
patient. In deciding on a treatment plan, the electro-
physiologist must understand and consider different drug
therapies, catheter ablation procedures, and surgical op-
tions (25,31). The mechanisms of action, metabolism,
risks, and pharmacology of both rate control and rhythm
control medications are an important part of the core
curriculum for EP training. The electrophysiologist must
be aware of the risks, beneﬁts, and potential adverse
outcomes of catheter ablation, surgical procedures, and
device therapy in patients with AF. EP training should
Zipes et al. J A C C V O L . 6 6 , N O . 2 4 , 2 0 1 5
2015 ACC/AHA/HRS CCEP Advanced Training Statement D E C E M B E R 2 2 , 2 0 1 5 : 2 7 6 7 – 8 0 2
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centered care and longitudinal care over extended pe-
riods of time. In addition, treatment options for AF are
evolving rapidly, and an effective EP training program
must have a mechanism to integrate these changes into
teaching and clinical practice.
4.4.7. VAs and Sudden Cardiac Death
Advanced training in EP includes the development of a
comprehensive understanding of the epidemiology, eti-
ology, and mechanisms of VAs and management of pa-
tients with VAs or who are at risk for sudden death due to
VT and ventricular ﬁbrillation. This includes an under-
standing of the deﬁnition and magnitude of the problem
of sudden cardiac death. Trainees must understand the
pathophysiological basis and diagnostic and management
approaches to patients with VAs, including ventricular
premature complexes, nonsustained VT, torsades de
pointes, sustained VT, and ventricular ﬁbrillation as
well as management of patients resuscitated from and at
risk for sudden cardiac death. The trainee must also
know how to manage VAs in a broad range of patient
populations, including athletes.
Topics that must be mastered include the patho-
physiological and genetic basis of inherited arrhythmia
syndromes such as long QT syndrome; short QT syn-
drome; catecholaminergic polymorphic VT; and J-wave
syndromes, including Brugada syndrome and early repo-
larization. The trainee must also understand the concepts
of arrhythmia pathophysiology, risk stratiﬁcation, and
management. This will include the assessment and man-
agement of patients with cardiomyopathies of either
ischemic or nonischemic origin, or other cardiomyopa-
thies, such as hypertrophic cardiomyopathy, arrhythmo-
genic right ventricular cardiomyopathy, sarcoidosis,
amyloidosis, and other inﬁltrative cardiomyopathies.
Trainees should understand when to refer a patient/
family to a cardiac geneticist and/or an inherited heart
disease center for further evaluation and management.
The trainee should also understand the signiﬁcance of
congenital heart disease in causing cardiac arrhythmias
and risk of sudden death, including the effect on clinical
decision making for patient management. There must be a
rigorous understanding of the pivotal ICD trials for both
primary and secondary prevention of sudden cardiac
death. Trainees must understand the principles of
arrhythmia genesis and understand potential proar-
rhythmic effects due to drugs, autonomic inﬂuences,
myocardial ischemia, and electrolyte abnormalities.
The trainee must learn to direct and carry out appro-
priate testing to diagnose and risk stratify patients. This
includes directing diagnostic testing such as imaging
(transthoracic and transesophageal echocardiography, CT,
and CMR) for the presence of structural heart disease,exercise testing, and coronary angiography. The trainee
must also understand the appropriate use of genetic
testing, including family testing for inherited arrhythmia
syndromes and cardiomyopathies, and be able to interpret
results with the assistance of a genetic counselor. Addi-
tionally, the trainee must understand the indications for
and be able to interpret other noninvasive testing (i.e.,
signal-averaged ECG, short- and long-term ECG moni-
toring, provocative pharmacological testing) and carry
out invasive arrhythmia testing when appropriate (i.e.,
programmed stimulation).
Management of VAs must be mastered in both the
acute and chronic settings and tailored to the patient’s
individual clinical needs and type of VA. This includes the
use of drugs (antiarrhythmic and sympathetic/para-
sympathetic modulators) with an understanding of their
pharmacodynamic and pharmacokinetic effects and the
potential for drug–drug and drug–device interactions in
the treatment of patients with premature ventricular
complexes, nonsustained VT, torsades de pointes, VT,
and ventricular ﬁbrillation. The trainee must understand
the indications for cardiac sympathetic denervation in
primary arrhythmia syndromes/cardiomyopathies. The
trainee must also understand the indications for, tech-
nique of, and complications associated with catheter
ablation for treatment of patients with premature ven-
tricular complexes, nonsustained VT, VT, and ventricular
ﬁbrillation triggers. The trainee must also know when to
advise implantation of an ICD following the assessment
of sudden cardiac death risk in patients with VAs and
various cardiac diseases.
4.4.8. Syncope
The trainee must acquire the medical knowledge and
clinical skills to diagnose and manage patients with syn-
cope. This will include knowledge of the differential
diagnosis; approach to diagnosis; and approach to treat-
ment, including risk stratiﬁcation of patients with
syncope.
The trainee will gain an understanding of the classi-
ﬁcations of syncope, including vasovagal or neurally-
mediated syncope (47), and syncope due to a cardiac
arrhythmia, including bradyarrhythmias (sinus brady-
cardia, AV block) and tachyarrhythmias (SVT and VT).
This understanding also includes an appreciation of
whether the syncope patient is at risk for sudden car-
diac death, such as in the setting of structural heart
disease or an inherited arrhythmia syndrome. The
trainee will also learn how to evaluate patients with a
thorough history, physical examination, and ECG inter-
pretation and to direct appropriate testing for possible
structural heart disease or inherited arrhythmia syn-
drome when indicated. Additionally, the trainee will
know the indications for other diagnostic modalities
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ILRs), tilt table testing, and invasive electrophysiolog-
ical testing.
The trainee must learn to manage patients with
neurally-mediated syncope (i.e., vasovagal syncope),
including the use of lifestyle measures, pharmacological
therapies, nonpharmacological interventions (e.g.,
lower-body compression garments), and the appropriate
indications for permanent pacing. The trainee will also
learn how to manage patients with syncope due to
cardiac arrhythmias, including the indications for per-
manent pacing for bradyarrhythmias, and the use of
pharmacological therapy and ablation for speciﬁc
tachyarrhythmias. The trainee must have an under-
standing of unusual causes of syncope and also know
the causes of postural intolerance, such as postural
orthostatic tachycardia syndrome, dysautonomias, and
orthostatic hypotension. Finally, the trainee must un-
derstand how to identify patients at risk for sudden
cardiac death for which an ICD or other therapies may
be indicated.
4.5. Nondevice Therapies
4.5.1. Antiarrhythmic Medications
The CCEP trainee should know and understand basic
concepts for therapeutic drug delivery of antiarrhythmic
medications including pharmacokinetic and pharmaco-
dynamic properties. The trainee should have a thorough
understanding of the indications, contraindications, and
dosages of commonly used antiarrhythmic medications,
including knowledge of drug–drug and drug–device in-
teractions, as well have an understanding of how drug
effects and toxicities can differ in speciﬁc populations of
patients depending on their age, sex, renal function,
and drug metabolism. The trainee should also have an
understanding of how to follow patients for development
of drug side effects and toxicities.
4.5.2. Catheter Ablation
Catheter ablation is an important component of advanced
fellowship training in CCEP, allowing effective treatment
for many cardiac arrhythmias. The trainee should acquire
a thorough understanding of the basic biophysics of
radiofrequency, cryoablation, and other ablative energy
sources, including the factors that inﬂuence how to
modify variables that affect ablation lesion size and
safety. This includes an in-depth understanding of how
to recognize and prevent complications from catheter
ablation.
4.5.3. Surgical Ablation
The electrophysiologist must be able to evaluate and
manage patients who undergo surgical ablation forarrhythmias. Surgical ablation is currently most
commonly performed for the treatment of AF, usually in
the context of concomitant cardiac surgery (31). As the
management options for patients with AF have expanded
over the past decade, surgical ablation options for AF
have also broadened to include stand-alone surgical pro-
cedures as well as hybrid approaches in which catheter
ablation and EP testing are performed in the same setting
or at a later date. Surgical ablation may also be utilized for
the treatment of VT.
The trainee must know the pathophysiological basis
of arrhythmia surgery. This includes an understanding
of the surgical approaches that involve the creation of
linear lesion sets in the left and right atria to achieve
pulmonary vein isolation. A variety of energy sources
may be utilized, and the trainee should have an un-
derstanding of the biophysics of the available energy
sources. The trainee must also know the indications,
techniques, and potential complications associated with
surgical treatment of cardiac arrhythmias. The trainee
must develop the skill to identify patients likely to
beneﬁt from surgical treatment of a cardiac arrhythmia
and to follow patients after surgery. This includes an
understanding of the comparative advantages and dis-
advantages of different lesion sets and energy sources,
including the potential for collateral damage. The
trainee should understand both the intraprocedural and
standalone surgical options for the management of the
left atrial appendage. The trainee must understand the
potential for lesion gaps that place the patient at risk
for atrial ﬂutter, which may require subsequent catheter
ablation.
4.6. Implantable Devices
The electrophysiologist implants a variety of CIEDs, which
include ILRs, permanent pacemakers, subcutaneous ICDs,
standard ICDs, and CRT devices (pacemaker or deﬁbril-
lator). Speciﬁc requirements are outlined in the following
text and include knowledge of the indications for each
device and the skills to perform the implantation safely
and manage any complications that may arise. The trainee
must acquire the skills for preprocedural planning. This
includes preprocedural assessment of hemodynamics,
sedation risks, and anticoagulation management. Other
preprocedural considerations include venous access and
device pocket location (i.e., right versus left, prepectoral
versus subpectoral). The trainee must also learn to recog-
nize venous or cardiac anomalies (encompassing congen-
ital and postsurgical abnormalities) that may affect
procedural techniques, including lead positioning and the
need for an epicardial pacing system. The trainee must
acquire the procedural skills to implant single- or dual-
chamber pacemakers safely, which includes the appro-
priate use of antibiotic therapy and other procedural
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niﬁcant bleeding, pneumothorax, or cardiac perforation.
The trainee must also be proﬁcient in the safe use of anti-
coagulants, procedural sedation (48–51), techniques to
minimize radiation exposure, and techniques to handle
suboptimal venous access. Additionally, the trainee must
learn to recognize potential complications quickly and be
able to initiate appropriate therapy.
The trainee must also acquire all of the programming
skills that relate to a particular CIED, including the
ability to interrogate (encompassing remote interroga-
tion), program, and troubleshoot devices and direct pa-
tient management. Knowledge of the bioengineering
aspects of implantable devices and how these devices
may be affected by environmental factors is also neces-
sary. The trainee should also be able to manage the CIED
patient who may be exposed to environmental electro-
magnetic interference. Management includes surgical
procedures, radiation therapy, and referring the patient
for magnetic resonance imaging. The trainee should
also be familiar with global systems of device safety
monitoring, the practitioner’s role in supporting these
safety systems, and protocols to manage patients with
devices or leads that are on recall or advisory. The trainee
must be able to review interrogations in both the clinic
and remote monitoring settings, including having the
ability to distinguish VAs from SVTs. Finally, trainees will
learn how to manage patients with end-of-life consider-
ations, including decisions about not replacing a device
when appropriate.
4.6.1. Pacemakers
The trainee will acquire the knowledge and skills needed
for permanent pacing. These include knowledge of the
indications for implantation, such as the appropriate de-
vice type (single versus dual chamber versus CRT) and the
skills to implant and manage patients with permanent
pacemakers. The trainee must also attain proﬁciency in
pacemaker programming both at the time of implant and
at follow-up. These programming skills should include
choice of pacing modes, understanding of timing intervals
(including AV delay, blanking, and refractory periods),
management of rate response algorithms and sensors,
mode switching algorithms, use of auto capture, and
programming skills to maintain battery longevity and
minimize ventricular pacing for non–CRT pacing systems.
Programming skills should also include an understanding
of the biophysics of pacing and of the technology of pac-
ing leads and generators. The trainee will also become
proﬁcient in troubleshooting pacemaker performance and
devising an appropriate management plan, including
having the ability to diagnose and determine the root
cause for problems such as loss of capture and inappro-
priate sensing, and to recognize the potential for apacemaker malfunction or inappropriate lead position
based on ECG. Troubleshooting also includes the ability to
identify pseudo-malfunction due to vendor-speciﬁc pac-
ing algorithms (e.g., algorithms that switch between
AAI and DDD modes) and other problems such as
distinguishing electromagnetic interference from lead
fracture or malfunction.
4.6.2. Implantable Cardioverter-Deﬁbrillators
Multiple large clinical trials have demonstrated that ICDs
are effective in primary and secondary prevention of sud-
den death and reduction of total mortality in select pop-
ulations (52). Trainees must thoroughly understand the
results from clinical trials and registry data as well as how
to incorporate professional guidelines with patient-
speciﬁc factors (including comorbidities and anticipated
psychosocial impact of ICDs) to select appropriate ICD
candidates. Trainees should gain expertise in selecting the
appropriate ICD device, including lead selection and
evaluation for subcutaneous ICDs. Technical proﬁciency in
device implantation is required and encompasses labora-
tory safety (including proper use of diagnostic radiation
and electrosurgical instruments), surgical asepsis, seda-
tion strategies, anticoagulation strategies, surgical site/
pocket management, vascular entry (including situations
with limited or anomalous venous access), lead implanta-
tion, lead evaluation (including sensing assessment,
threshold testing, and anatomic location by ﬂuoroscopy),
and deﬁbrillation testing (including understanding deﬁ-
brillationwaveforms and deﬁbrillation probability curves).
It is also important to understand the role of DFT testing,
when not to perform DFT testing, and how to use alternate
lead conﬁgurations and/or device programming to manage
patients with a high DFT. The operator must understand
ICD-related complications, including how to prevent,
identify, and manage these complications both intra-
operatively and long term. Knowledge is required of
interrogating and programming ICDs from various manu-
facturers, both in-person and remotely, including
reviewing diagnostic data; analyzing intracardiac elec-
trograms; distinguishing SVTs from VAs; designing long-
term follow-up programs; minimizing ventricular pacing
if appropriate; performing noninvasive programmed
stimulation; troubleshooting; and optimally programming
ventricular tachyarrhythmia detection, discrimination,
and termination algorithms (to minimize inappropriate
shocks and favor antitachycardia pacing over shocks
for VT termination) (53). The trainee must understand
drug–device and environment–device (electromagnetic)
interactions.
4.6.3. Resynchronization Therapy
Multiple large clinical trials have demonstrated that car-
diac resynchronization improves quality of life, cardiac
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Trainees must thoroughly understand the results from
clinical trials and registry data as well as the recommen-
dations from professional societies; this includes aware-
ness of variables that potentially modify the anticipated
response to CRT to reduce the probability of selecting
nonresponders. The trainee should develop technical
proﬁciency in CIED implantation, with speciﬁc additional
skills for CRT, including detailed knowledge of cardiac
venous anatomy and expertise in lead placement in the
coronary sinus system. The operator must understand
CRT-related complications, including how to prevent,
identify, and manage these complications both intra-
operatively and long term. When anatomy precludes
transvenous left ventricular lead placement, the trainee
should be familiar with alternative left ventricular lead
placement, including the epicardial approach. Trainees
should be skilled in managing patients with heart fail-
ure and understand how to evaluate, follow-up, and
optimize device programming (including AV and inter-
ventricular timing) using ECG analysis, device-based
algorithms, echocardiography, and/or alternative imag-
ing modalities.
4.6.4. Implantable Loop Recorders
ILRs are increasingly used to detect sporadic arrhythmias.
Trainees should thoroughly understand the indications
for and considerations in recommending an ILR.
The trainee should develop technical proﬁciency in
implanting and explanting ILRs, including monitoring
and managing potential complications. Knowledge is
required of interrogating and programming ILRs in-
person and remotely; this includes correct electrogram
analysis and rhythm determination.
4.6.5. Left Atrial Appendage Occlusion/Ligation
Surgical and percutaneous left atrial appendage occlusion
represents an emerging alternative strategy to systemic
anticoagulation for reducing risk of thromboembolism
and stroke in patients with AF (26,54). Trainees should
be knowledgeable regarding the rationale, indications,
technical approach, risks, and complications associated
with different left atrial appendage occlusion/ligation
strategies. They should be able to identify potential can-
didates for percutaneous or surgical left atrial appendage
occlusion/ligation. Trainees should understand how to
manage patients following left atrial appendage occlu-
sion/ligation, including managing anticoagulant and/or
antithrombotic therapy, and evaluating device efﬁcacy
long-term. For trainees seeking to perform appendage
occlusion procedures, additional technical expertise is
required (in some instances as part of a multidisciplinary
team), including proﬁciency in placing and possiblyrevising the occlusion device; recognizing and managing
complications (including expertise in managing pericar-
dial space complications); and interpreting advanced
imaging modalities, including CT scanning, ﬂuoroscopy,
cine with contrast, and echocardiography.
4.6.6. Lead Management
Trainees should be knowledgeable about strategies to
prevent lead- and device-related complications, including
during CIED implantation, revision, and generator
replacement. Heart rhythm specialists should understand
the basic design of leads. Trainees should learn how to
track the performance of a wide variety of leads from
different manufacturers, monitor individuals with leads
under advisory, and diagnose and manage lead failure.
Trainees should thoroughly understand the indications
for lead extraction and know how to manage patients
undergoing extraction perioperatively including those
with device infection and/or requiring subsequent CIED
therapy (32). For trainees seeking to perform transvenous
lead extraction, additional expertise is required in the
technical aspects of the procedure, including exposure as
the primary operator to various venous entry sites,
extraction tools, and techniques under the direct super-
vision of an appropriately trained physician. The operator
must understand potential complications of lead extrac-
tion, including how to prevent, identify, and manage
these complications as part of a multidisciplinary extrac-
tion team.5. EVALUATION OF PROFICIENCY
Evaluation tools in EP include direct observation by
instructors, case logbooks, conference and case pre-
sentations, multisource evaluations, trainee portfolios,
and simulation. Self-assessment programs are available
through the ACC and HRS (55,56). Training directors and
trainees are encouraged to incorporate these resources in
the course of training. Following completion of CCEP
training, trainees will be eligible to take the ABIM Board
Certiﬁcation Examination in EP.
Judgment, case management, and bedside and proce-
dural skills must be evaluated in every trainee. Quality of
care and follow-up; reliability; judgment or decisions or
actions that result in complications; interaction with
other physicians, patients, and laboratory support staff;
initiative; and the ability to make appropriate decisions
independently should be considered. Trainees should
maintain records of participation and advancement in
the form of a Health Insurance Portability and Account-
ability Act–compliant electronic database or logbook that
meets ACGME reporting standards and summarizes
pertinent clinical information (number of cases,
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for each encounter.
Under the guidance of the program director, faculty
should record and verify each trainee’s experiences,
assess performance, and document satisfactory achieve-
ment. The program director is responsible for conﬁrming
experience and competence and reviewing the overall
progress of individual trainees with the Clinical Compe-
tency Committee to ensure achievement of selected
training milestones and identify areas in which additional
focused training may be required.
6. MAINTENANCE OF COMPETENCY
As indicated in the competency table, there are a
number of evaluation tools to ensure achievement of
the knowledge, skills, and behaviors required for suc-
cessful completion of CCEP fellowship. It is also
important to ensure that learning is a lifelong process
and that the core CCEP competencies are maintained
over the course of a career. A number of mechanisms
can aid in this regard; traditionally, this has included
formal ABIM maintenance of EP certiﬁcation. Individual
practitioner outcomes, quality metrics, and peer review
can also be important components of demonstration of
competency.
For successful graduation from an accredited CCEP
training program, a minimum number of various EP
procedures has been suggested. Similarly, minimum
annual numbers and a blend of procedures have been
proposed for assurance of continued competence
(13,20,57–61). It is important to recognize that there is a
growing subspecialization career focus within EP, in
which some highly skilled practitioners limit the scope oftheir clinical activity to pacemaker and deﬁbrillator im-
plantation and follow-up, whereas others focus their
efforts on complex ablation, and still others do more
straightforward ablations (not those that are complex)
but have little continuing experience in implantable
device work. Thus, although maintenance of some CCEP
competencies is an expectation for all clinical cardiac
electrophysiologists, the maintenance of other CCEP
competencies—and the evaluation tools to assess them—
can be career-focused.
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Associate Professor
of Medicine
Content Reviewer,
ACC EP Section
Leadership
Council
None None None None None None
Marwan Refaat American University of Beirut
Medical Center—Assistant
Professor of Medicine
Content Reviewer,
ACC EP Section
Leadership
Council
None None None None None None
Lynda Rosenfeld Yale University School of
Medicine—Director, Yale
University Clinical Cardiac
Electrophysiology Fellowship
Program
Content Reviewer,
EP Training
Program
Director
None None None  Medtronic†  Boston
Scientiﬁc*
 Medtronic*
 St. Jude
Medical*
None
Peter Santucci Loyola University—
Electrophysiology Training
Program Director; Professor
of Medicine
Content Reviewer,
EP Training
Program
Director
None None None None  Biosense
Webster*
 Biotronik*
 Boston
Scientiﬁc*
 Medtronic*
None
Komandoor
Srivathsan
Mayo Clinic—Associate Professor,
College of Medicine
Content Reviewer,
EP Training
Program
Director
 St. Jude Medical  Biosense Webster None None None None
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Gregory Supple University of Pennsylvania Health
System—Associate Director,
Cardiac Electrophysiology
Fellowship Program; Assistant
Professor of Clinical Medicine
Content Reviewer,
EP Training
Program
Director
 Biotronik
 St. Jude Medical
None None  Boston Scientiﬁc
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This table reﬂects peer reviewers’ relationships with industry and other entities that were reported and deemed to be relevant to this document, as well as employment, representation in the review process, and reporting categories. Names are listed in
alphabetical order within each category of review. The table does not necessarily reﬂect relationships with industry at the time of publication. A person is deemed to have a signiﬁcant interest in a business if the interest represents ownership of $5% of
the voting stock or share of the business entity, or ownership of $$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year.
Relationships in this table are modest unless otherwise noted. Please refer to http://www.acc.org/guidelines/about-guidelines-and-clinical-documents/relationships-with-industry-policy for deﬁnitions of disclosure categories, relevance, or additional
information about the ACC Disclosure Policy for Writing Committees.
*Signiﬁcant relationship.
†No ﬁnancial beneﬁt.
ABIM indicates American Board of Internal Medicine; ACPC, Adult Congenital and Pediatric Cardiology; AIG, Assembly of International Governors; BOG, Board of Governors; BOT, Board of Trustees; CMC, Competency Management Committee; CV,
Cardiovascular; EP, Electrophysiology; UCSF, University of California, San Francisco; other abbreviations as in Appendix 1.
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2802APPENDIX 3. ABBREVIATION LISTABIM ¼ American Board of Internal Medicine
ACC ¼ American College of Cardiology
ACGME ¼ Accreditation Council for Graduate Medical
Education
AF ¼ atrial ﬁbrillation
AHA ¼ American Heart Association
AP ¼ accessory pathway
AV ¼ atrioventricular
CCEP ¼ clinical cardiac electrophysiology
CIED ¼ cardiac implantable electronic devices
CMR ¼ cardiovascular magnetic resonance
COCATS ¼ Core Cardiovascular Training Statement
CRT ¼ cardiac resynchronization therapy
CT ¼ computed tomography
DFT ¼ deﬁbrillation threshold
ECG ¼ electrocardiogram
EP ¼ electrophysiology
HRS ¼ Heart Rhythm Society
ICD ¼ implantable cardioverter-deﬁbrillator
ILR ¼ implantable loop recorder
RWI ¼ relationships with industry
SVT ¼ supraventricular tachycardia
VA ¼ ventricular arrhythmia
VT ¼ ventricular tachycardia
